ArticleMedicine2026
Global temporal trends and projections for the incidence of chlamydial infection among women of childbearing age over the next decade.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Women of childbearing age (WCBA) are at unreasonable risk of excruciating pregnancy-related complications associated with chlamydial infection, constituting a paramount peril to global public health. This study aims to demonstrate the temporal tendencies of chlamydial infection in WCBA and prognosticate its future incidence, providing momentous illumination for precise prevention and management blueprints. Chlamydial infection incidence data was from Global Health Data 2021. An age-period-cohort (APC) model was implemented to probe trends in distinct age groups, periods, and birth cohorts, and a Bayesian APC model was utilized to previse future epidemiological trajectories. Between 1990 and 2021, global chlamydia cases rose significantly from 65,012,610 to 99,376,268. age-standardized incidence rate exhibited a relatively stable trajectory, increasing only slightly from 4861.3 per 100,000 to 5099.2 per 100,000 with a global net drift of -0.003%. High sociodemographic index areas diverged from global trends, demonstrating a yearly positive net drift of 0.643%. For the age effects of chlamydia incidence rate, all of the models displayed a similar "n"-shaped distribution, with the highest risk being noticed in childbearing aged 25 to 34 years, followed by a subsequent decline as advanced ages. The Bayesian APC model predicted a total of 102.05 million global cases in WCBA by 2030, with an expected moderate diminution in the age-standardized incidence rate. The expectancy for the management and prevention of chlamydial infection was inadequate in certain countries, including Turkmenistan. This study revealed a persistent rise in chlamydial infection among women of childbearing age, with the highest incidence observed in those aged 25 to 34 years. Despite the slight predicted decline in global incidence by 2030, significant management gaps still remained, particularly in countries like Turkmenistan. Targeted interventions and improved healthcare access are crucial to reduce the burden and enhance disease control efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.